The role of resection for patients with renal carcinoma
Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable meta...
Gespeichert in:
| Veröffentlicht in: | Current oncology reports 2001-09, Vol.3 (5), p.424-432 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 432 |
|---|---|
| container_issue | 5 |
| container_start_page | 424 |
| container_title | Current oncology reports |
| container_volume | 3 |
| creator | Flanigan, R C Yonover, P M |
| description | Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable metastases. Recent findings from a Southwest Oncology Group trial strongly suggest that cytoreductive nephrectomy, combined with immunotherapy, may also result in improved survival in patients with unresectable metastases. |
| doi_str_mv | 10.1007/s11912-001-0029-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71062662</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71062662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c212t-e6d26c10863a67456af277b5b800134285b22b1e6c618b6223cd3ed8d89d47b13</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMo7rr6A7xIT96imUmbpEdZ_IIFL-s5JGnKVtpmTbqI_94sXfAwzMC873w8hNwCewDG5GMCqAEpY5ADa8rOyBIqXlKBoj4_1sgplzVbkKuUvrKGMcUuyQKgVDWW5ZLI7c4XMfS-CG0RffJu6sJYtCEWezN1fpxS8dNNu9wbTV84E103hsFck4vW9MnfnPKKfL48b9dvdPPx-r5-2lCHgBP1okHhgCnBjZBlJUyLUtrKqnw0L1FVFtGCF06AsgKRu4b7RjWqbkppga_I_Tx3H8P3wadJD11yvu_N6MMhaQksPyswC2EWuhhSir7V-9gNJv5qYPpIS8-0dF6sj7Q0y5670_CDHXzz7zjh4X9Us2NW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71062662</pqid></control><display><type>article</type><title>The role of resection for patients with renal carcinoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Flanigan, R C ; Yonover, P M</creator><creatorcontrib>Flanigan, R C ; Yonover, P M</creatorcontrib><description>Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable metastases. Recent findings from a Southwest Oncology Group trial strongly suggest that cytoreductive nephrectomy, combined with immunotherapy, may also result in improved survival in patients with unresectable metastases.</description><identifier>ISSN: 1523-3790</identifier><identifier>EISSN: 1534-6269</identifier><identifier>DOI: 10.1007/s11912-001-0029-0</identifier><identifier>PMID: 11489244</identifier><language>eng</language><publisher>United States</publisher><subject>Carcinoma, Renal Cell - immunology ; Carcinoma, Renal Cell - secondary ; Carcinoma, Renal Cell - surgery ; Combined Modality Therapy ; Humans ; Immunotherapy ; Infarction - immunology ; Kidney - blood supply ; Kidney Neoplasms - immunology ; Kidney Neoplasms - pathology ; Kidney Neoplasms - surgery ; Nephrectomy ; Prognosis</subject><ispartof>Current oncology reports, 2001-09, Vol.3 (5), p.424-432</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c212t-e6d26c10863a67456af277b5b800134285b22b1e6c618b6223cd3ed8d89d47b13</citedby><cites>FETCH-LOGICAL-c212t-e6d26c10863a67456af277b5b800134285b22b1e6c618b6223cd3ed8d89d47b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11489244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flanigan, R C</creatorcontrib><creatorcontrib>Yonover, P M</creatorcontrib><title>The role of resection for patients with renal carcinoma</title><title>Current oncology reports</title><addtitle>Curr Oncol Rep</addtitle><description>Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable metastases. Recent findings from a Southwest Oncology Group trial strongly suggest that cytoreductive nephrectomy, combined with immunotherapy, may also result in improved survival in patients with unresectable metastases.</description><subject>Carcinoma, Renal Cell - immunology</subject><subject>Carcinoma, Renal Cell - secondary</subject><subject>Carcinoma, Renal Cell - surgery</subject><subject>Combined Modality Therapy</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Infarction - immunology</subject><subject>Kidney - blood supply</subject><subject>Kidney Neoplasms - immunology</subject><subject>Kidney Neoplasms - pathology</subject><subject>Kidney Neoplasms - surgery</subject><subject>Nephrectomy</subject><subject>Prognosis</subject><issn>1523-3790</issn><issn>1534-6269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAQhoMo7rr6A7xIT96imUmbpEdZ_IIFL-s5JGnKVtpmTbqI_94sXfAwzMC873w8hNwCewDG5GMCqAEpY5ADa8rOyBIqXlKBoj4_1sgplzVbkKuUvrKGMcUuyQKgVDWW5ZLI7c4XMfS-CG0RffJu6sJYtCEWezN1fpxS8dNNu9wbTV84E103hsFck4vW9MnfnPKKfL48b9dvdPPx-r5-2lCHgBP1okHhgCnBjZBlJUyLUtrKqnw0L1FVFtGCF06AsgKRu4b7RjWqbkppga_I_Tx3H8P3wadJD11yvu_N6MMhaQksPyswC2EWuhhSir7V-9gNJv5qYPpIS8-0dF6sj7Q0y5670_CDHXzz7zjh4X9Us2NW</recordid><startdate>200109</startdate><enddate>200109</enddate><creator>Flanigan, R C</creator><creator>Yonover, P M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200109</creationdate><title>The role of resection for patients with renal carcinoma</title><author>Flanigan, R C ; Yonover, P M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c212t-e6d26c10863a67456af277b5b800134285b22b1e6c618b6223cd3ed8d89d47b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Carcinoma, Renal Cell - immunology</topic><topic>Carcinoma, Renal Cell - secondary</topic><topic>Carcinoma, Renal Cell - surgery</topic><topic>Combined Modality Therapy</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Infarction - immunology</topic><topic>Kidney - blood supply</topic><topic>Kidney Neoplasms - immunology</topic><topic>Kidney Neoplasms - pathology</topic><topic>Kidney Neoplasms - surgery</topic><topic>Nephrectomy</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flanigan, R C</creatorcontrib><creatorcontrib>Yonover, P M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current oncology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flanigan, R C</au><au>Yonover, P M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of resection for patients with renal carcinoma</atitle><jtitle>Current oncology reports</jtitle><addtitle>Curr Oncol Rep</addtitle><date>2001-09</date><risdate>2001</risdate><volume>3</volume><issue>5</issue><spage>424</spage><epage>432</epage><pages>424-432</pages><issn>1523-3790</issn><eissn>1534-6269</eissn><abstract>Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable metastases. Recent findings from a Southwest Oncology Group trial strongly suggest that cytoreductive nephrectomy, combined with immunotherapy, may also result in improved survival in patients with unresectable metastases.</abstract><cop>United States</cop><pmid>11489244</pmid><doi>10.1007/s11912-001-0029-0</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1523-3790 |
| ispartof | Current oncology reports, 2001-09, Vol.3 (5), p.424-432 |
| issn | 1523-3790 1534-6269 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71062662 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Carcinoma, Renal Cell - immunology Carcinoma, Renal Cell - secondary Carcinoma, Renal Cell - surgery Combined Modality Therapy Humans Immunotherapy Infarction - immunology Kidney - blood supply Kidney Neoplasms - immunology Kidney Neoplasms - pathology Kidney Neoplasms - surgery Nephrectomy Prognosis |
| title | The role of resection for patients with renal carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A44%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20resection%20for%20patients%20with%20renal%20carcinoma&rft.jtitle=Current%20oncology%20reports&rft.au=Flanigan,%20R%20C&rft.date=2001-09&rft.volume=3&rft.issue=5&rft.spage=424&rft.epage=432&rft.pages=424-432&rft.issn=1523-3790&rft.eissn=1534-6269&rft_id=info:doi/10.1007/s11912-001-0029-0&rft_dat=%3Cproquest_cross%3E71062662%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71062662&rft_id=info:pmid/11489244&rfr_iscdi=true |